EP0506653A1 - Compositions a base d'acides amines - Google Patents

Compositions a base d'acides amines

Info

Publication number
EP0506653A1
EP0506653A1 EP19870906193 EP87906193A EP0506653A1 EP 0506653 A1 EP0506653 A1 EP 0506653A1 EP 19870906193 EP19870906193 EP 19870906193 EP 87906193 A EP87906193 A EP 87906193A EP 0506653 A1 EP0506653 A1 EP 0506653A1
Authority
EP
European Patent Office
Prior art keywords
amino acid
acid composition
possibly
ornithine
tyrosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870906193
Other languages
German (de)
English (en)
Inventor
Raymond Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATURAL VITALITY Ltd
Original Assignee
NATURAL VITALITY Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NATURAL VITALITY Ltd filed Critical NATURAL VITALITY Ltd
Publication of EP0506653A1 publication Critical patent/EP0506653A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Une composition chimique, constituée essentiellement de L-arginine et de L-ornithine ainsi qu'éventuellement d'un petit mélange d'au moins un autre composant, est utilisée pour maigrir, éventuellement en conjonction avec de la L-tyrosine. Un ou plusieurs des acides aminés peuvent être remplacés par un groupe équivalent.
EP19870906193 1986-09-17 1987-09-17 Compositions a base d'acides amines Withdrawn EP0506653A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08622417A GB2199243A (en) 1986-09-17 1986-09-17 Pharmaceutical compositions comprising ornithine and arginine
GB8622417 1986-09-17

Publications (1)

Publication Number Publication Date
EP0506653A1 true EP0506653A1 (fr) 1992-10-07

Family

ID=10604341

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870906193 Withdrawn EP0506653A1 (fr) 1986-09-17 1987-09-17 Compositions a base d'acides amines

Country Status (4)

Country Link
EP (1) EP0506653A1 (fr)
AU (1) AU7969187A (fr)
GB (1) GB2199243A (fr)
WO (1) WO1988001865A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2745498A1 (fr) * 1996-02-29 1997-09-05 Giroux Jean Marc Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite
FR2794974B1 (fr) 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
US8968799B2 (en) * 2006-09-01 2015-03-03 Rise-N-Shine L.L.C. Time delayed release mechanism for energizing composition and method of use
FR2987270A1 (fr) * 2012-02-29 2013-08-30 Agronomique Inst Nat Rech Produit de combinaison pour le traitement du surpoids et/ou l'amelioration de la silhouette

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR926M (fr) * 1961-01-18 1961-11-13
FR958M (fr) * 1961-01-18 1961-11-27
CA939265A (en) * 1967-11-18 1974-01-01 Yoshitaka Ikezuki Injectable compositions for alleviating the pain incurred from administrations of injections
ZA716628B (en) * 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
US3867539A (en) * 1973-04-27 1975-02-18 Us Health Method of producing anorexia as a treatment for obesity
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
ATE9436T1 (de) * 1980-06-09 1984-10-15 Leopold & Co. Chem. Pharm. Fabrik Gesellschaft M.B.H. Infusionsloesung zum schutz der leber und zur verbesserung von deren funktion und verfahren zu deren herstellung.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8801865A1 *

Also Published As

Publication number Publication date
AU7969187A (en) 1988-04-07
WO1988001865A1 (fr) 1988-03-24
GB8622417D0 (en) 1986-10-22
GB2199243A (en) 1988-07-06

Similar Documents

Publication Publication Date Title
ES8500561A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas dermicas de accion prolongada y continua a base de acidos grasos esenciales
DE3787061D1 (de) Chelatierte aminosaeurezusammensetzungen zur verabreichung an bestimmte gewebestellen.
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
MX172918B (es) Composicion a base de l-3,4-dihidroxifenilalanina
SE8703938D0 (sv) Peptide derivatives
BE901007A (fr) Comprimes pharmaceutiques a liberation etalee et procede pour les preparer.
Connors et al. The pharmacology and tumour growth inhibitory activity of 1-aminocyclopentane-1-carboxylic acid and related compounds
SE8901041L (sv) Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning
EP0506653A1 (fr) Compositions a base d'acides amines
FR2355865A1 (fr) Perfectionnements aux co-condensats polyester/polyamide
EP0799828A3 (fr) Pyrimido [1,2-a] indoles
WO2002102360A3 (fr) Compositions a base d'acides amines destinees a ameliorer la fonction ventriculaire du myocarde chez des patients souffrant du diabete
ATE71388T1 (de) Sofort vernetzbare zusammensetzung.
CA2047802A1 (fr) Compositions pharmaceutiques
WO2002002092A3 (fr) Compositions a base d'aminoacides permettant d'ameliorer les performances musculaires
DK526087A (da) Antikonvulsive aminosyrederivater
FR2422403A1 (fr) Compositions therapeutiques diuretiques a effet rapide, a base d'acide 4-chloro-n-furfuryl-5-sulfamoylanthranilique et de composes de pteridine
EP0063328A3 (fr) Compositions contenant la sécrétine et procédé pour prévenir l'adsorption de la sécrétine
ES8608861A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.
CA2091602A1 (fr) Solution d'acides amines tres concentree
Campbell et al. Paradoxical decrease in norepinephrine content of adult mouse spleen and heart after neonatal nerve growth factor treatment
KR920700683A (ko) t-PA의 가용화
NO964815L (no) Ernæringsformulering
Buston et al. The nitrogen requirements of Nematospora gossypii in synthetic media
Matuno On the Essential Amino Acid Intake of the Japanese People (Report 12) Intake of the Essential Amino Acid from Animal Origin and Vegetable Origin by the Japanese People Calculated from the National Nutrition Survey in Japan from 1946 to 1973

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19890914

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19921029

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19930309